EQUITY RESEARCH MEMO
InfoBionic.Ai
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)60/100
InfoBionic.Ai is a Boston-based digital health company pioneering AI-driven remote cardiac monitoring through its MoMe ARC® platform. By converting complex cardiac data into actionable clinical insights, the platform enables hospital-grade diagnostics from any care setting, aiming to improve patient outcomes through earlier interventions. Founded in 2015, the company operates in the rapidly expanding remote monitoring and AI/ML healthcare sectors, but remains private with limited publicly available financial or operational details.
Upcoming Catalysts (preview)
- Q2 2026FDA Clearance for Expanded Indications (e.g., Pediatric or Extended Wear)70% success
- Q3 2026Strategic Partnership with Major Health System or Telehealth Platform50% success
- Q4 2026Publication of Key Clinical Validation Study in Peer-Reviewed Journal60% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)